InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
5,505.00
(
-0.71%
)
US TECH 100
19,000.00
(
-0.94%
)
Dow Jones
40,287.53
(
-0.93%
)
Brent Oil
81.88
(
0.00%
)
Bitcoin
66,598.29
(
-0.18%
)
Post# of 291
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Boxsterfan

Send PM Follow Ignore
Followers 7
Posts 1702
Boards Moderated 0
Alias Born 01/14/2010

Boxsterfan

Re: gdog post# 281

Tuesday, 07/16/2024 3:59:50 PM

Tuesday, July 16, 2024 3:59:50 PM

Post# of 291
This is Bottom Swing Plays Chat, right? Recent Bottom Swing on SLS was a brief dip to $0.81 (for about 2 minutes) a few weeks back. Didn't get that.

I'm buying SLS now because

1. Phase 3 Regal Trial data imminent for drug GPS.
2. In the last 30 days, their drug SLS009 has received two (2) Priority Review Vouchers for Rare Pediatic Disease Designation (RPDD) because the drug has a 99%+ overall response rate in patients.
3. Commercial team left in March 2024. Company is looking to be bought out and actively seeking such. Abbvie, Merck, Novartis are my guesses for interested parties.

Thx,
The Boxsterfan
Dean Janes is king of Angry Birds!!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up